Organisation paid for research Program year 2024 Source: CMS Open Payments

Acclaim Dermatology

Neither a doctor nor a teaching hospital

Research payments

$210,094

14 payments

Through program year 2024, Acclaim Dermatology is reported as receiving $210,094 in research payments, across 14 payments.

By program year

5 rows

Year	Kind	Amount	Payments
2024	Research	$32,666	2
2023	Research	$18,886	2
2022	Research	$8,750	5
2021	Research	$138,554	2
2020	Research	$11,237	3

Breakdown

Who paid Research payments · program years 2020–2024

Amgen Inc. $207,967 12 payments
Pfizer Inc. $2,126 2 payments

Studies the money was for Research payments · program years 2020–2024

ABP 654 P3 PsO Study $138,554 2 payments
Ph3 Otezla in Peds mild/mod PsO PMR $32,666 2 payments
Ph3 Otezla in Peds mild/mod PsO (PMR) $16,830 1 payment
ABP 654 Phase 3 PsO Study $11,167 2 payments
Evaluation of Safety and Efficacy of Avacopan in Subjects With Moderate to Severe Hidradenitis Suppurativa $8,750 5 payments
A Phase 23 Twopart Study to Evaluate the Efficacy and Longterm Safety With Oral Etrasimod 2 MG Once Daily in Adult Participants With Moderatetosevere Atopic Dermatitis With A History of Prior Systemic Treatment Failure $2,056 1 payment
A Phase 3B Randomized Doubleblind Doubledummy Active Controlled Multicenter Study Assessing the Efficacy and Safety of Abrocitinib Compared With Dupilumab in Adult Participants on Background Topical Therapy With Moderate to Severe Atopic Dermatitis $70 1 payment

What you are looking at

A noncovered recipient is an organisation paid for research that is neither an individual clinician nor a teaching hospital — typically a contract research organisation, a foundation or a trial site network. They receive 81% of all reported research money, which is why they appear here at all.